Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
05/2003
05/08/2003CA2463441A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003CA2462206A1 Substituted thioacetamides
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308157A1 N-heterocyclic carbene complexes and the use thereof
05/07/2003EP1307431A2 Efficient ligand-mediated ullmann coupling of anilines and azoles
05/07/2003EP1019358B1 3,3-diarylpropylamines , their use and preparation
05/07/2003EP0889880B1 Eprosartan dihydrate and a process for its production and formulation
05/07/2003EP0889863B1 Surface modified carbonate materials
05/07/2003EP0751765B1 Sulfonamide derivatives and their use
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/07/2003CN1416422A Substituted benzoylcyclohexenones
05/07/2003CN1416416A Androgen receptor suppressors in treatment of hirsutism,acne and androgenetic alopecia
05/06/2003US6559172 Treatment of bacterial infections, particularly through the inhibition of FAB I. and antiobiotics
05/06/2003US6559157 Dihydronaphthalene compounds
05/06/2003US6559147 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4 -(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine, for example
05/06/2003US6559140 Cyclic and bicyclic diamino histamine-3 receptor antagonists
05/06/2003US6558649 Vitronectin receptor antagonist pharmaceuticals
05/02/2003EP1306365A2 Cobalt supported catalysts for hydrogenation of nitriles
05/02/2003EP1306085A1 2-Cyclohexyl-4-phenyl-1H-imidazole derivatives as ligands for the neuropeptide Y5 receptor
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305295A1 Imidazole derivatives
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305288A1 Potassium channel inhibitors
05/02/2003EP1305274A2 Novel c-4 substituted retinoids
05/02/2003EP1305270A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
05/02/2003EP1305028A2 Antimicrobial biaryl compounds
05/02/2003EP1305024A1 Method for treating fibrotic diseases or other indications ic
05/02/2003EP0910563B1 Integrin receptor antagonists
05/02/2003CA2410364A1 5-heterocyclo-pyrazoles
05/01/2003WO2003035626A2 Azole derivatives and pharmaceutical compositions containing them
05/01/2003WO2003035613A2 Nitrogen heterocycle inhibitors of aspartyl protease
05/01/2003WO2003035609A1 Zwitterionic imides
05/01/2003WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
05/01/2003WO2003006443A3 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy
05/01/2003US20030083518 Substituted alcohols useful in treatment of Alzheimer's disease
05/01/2003US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives
05/01/2003US20030083500 Imidazonaphthyridines
05/01/2003US20030083489 Method of synthesizing polynucleotides using ionic liquids
05/01/2003US20030083360 Compaction process for manufacture of sodium phenytoin dosage form
05/01/2003US20030083353 Beta-secretase inhibitors
05/01/2003US20030083352 Cyclization of a 2-cyano-2-ester-ethylenamine with a primary amine to a 4-ester imidazole
05/01/2003US20030083349 Antimalaria agents
05/01/2003US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity
05/01/2003US20030080320 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base
05/01/2003US20030080312 Reacting organic base and an alkylating agent, wherein the alkylating agent is a fluorinated ester or an alkyl sulfonate
05/01/2003CA2463290A1 Zwitterionic imides
05/01/2003CA2463101A1 Azole derivatives and pharmaceutical compositions containing them
04/2003
04/30/2003CN1414956A Substituted piperazine derivatives as MIP inhibitors
04/30/2003CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof
04/30/2003CN1107056C Process for preparation of clonidine derivatives
04/29/2003US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery
04/29/2003US6555692 Polylactams having imidazole or pyrrole rings specifically bind with subnanomolar affinity to a predetermined DNA sequence; use in molecular biology and diagnostic medicine; gene expression control; target the minor groove of B-form
04/29/2003US6555572 Benzylated PDE4 inhibitors
04/29/2003US6555566 Methods and materials for treating and preventing inflammation of mucosal tissue
04/29/2003US6555563 Compounds based on 2-aryl-5-(imidazol-2-yl)-1,3,4-thiadiazole or the corresponding 1,3,4-oxadiazole; selective COX-2 (cyclooxygenase-2) inhibitors; side effect reduction
04/29/2003US6555541 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
04/29/2003US6554872 Cationic aminodianthraquinones, use, dyeing compositions containing them and methods of dyeing
04/29/2003CA2134347C Thiazole or imidazole derivatives as maillard reaction inhibitors
04/29/2003CA2032988C Process for preparing 1-phenylimidazoline-2,5-dione
04/24/2003WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof
04/24/2003WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
04/24/2003WO2003033473A1 Novel 5-substituted hydantoin derivative and process for producing the same
04/24/2003WO2003033461A1 Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens
04/24/2003WO2003033447A1 Luminous compounds and labeling reagents using the same
04/24/2003WO2003032980A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/24/2003WO2002022553A3 Non-natural basic amino acids, their preparation and use
04/24/2003US20030078436 Process for the catalytic preparation of N-acylglycine derivatives
04/24/2003US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
04/24/2003US20030078418 Useful potentiators of beta -lactam antibiotics; therapy
04/24/2003US20030078287 For controlling plant and animal pests
04/24/2003US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
04/24/2003US20030078265 Inhibitors of nitric oxide synthase (nos)
04/24/2003US20030078261 Prostaglandin agonists
04/24/2003US20030078257 Methods of treating tumors
04/24/2003US20030078239 Ketone compounds and compositions for cholesterol management and related uses
04/24/2003CA2464435A1 Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens
04/24/2003CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof
04/23/2003EP1303541A1 Gel compositions containing metronidazole
04/23/2003EP1303501A1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
04/23/2003EP1303494A2 Potassium channel inhibitors
04/23/2003EP1303493A1 Method for the production of n,n'-carbonyldiazoles and azolide salts
04/23/2003EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/23/2003EP1303270A1 Method for treating cryptorchidism
04/23/2003EP1303249A1 Antimycotic nail varnish composition
04/23/2003EP1086179B1 Energy transfer assay method and reagent
04/23/2003EP1005447B1 Method for producing long-chain glycine-n,n-diacetic acid derivatives
04/23/2003EP0993442B1 Hydrazine derivatives
04/23/2003EP0906311B1 N-sulfonylimidazoles used as fungicides
04/23/2003CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
04/23/2003CN1106387C PDEIV inhibiting 2-cyanoiminoimidazole derivatives
04/23/2003CA2403307A1 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
04/22/2003US6552216 Molecular model for VLA-4 inhibitors
04/22/2003US6552065 Antiproliferative agents
04/22/2003US6552061 Amino acid derivatives and anti-inflammatory agents
04/22/2003US6552060 Asymmetric disulfides and methods of using same
04/22/2003US6552051 Useful as high energy oxidizing agents in explosive and propellant formulations, and drugs for vasodilation
04/22/2003US6552047 H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use
1 ... 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 ... 345